Shandong Buchang Pharmaceuticals Co., Ltd. (603858.SH) has announced plans to invest in a new subsidiary to strengthen its strategic development layout. This move aims to gain a competitive advantage in the market through more refined management and to boost business growth.

The new entity, to be named Shandong Buchang Shengshi Pharmaceutical Co., Ltd., will have a registered capital of 50 million yuan. Buchang Pharmaceuticals intends to contribute 33.5 million yuan for a 67% equity stake in the subsidiary.